A review of the epidemiology, biology and pathogenesis of HIV

Journal of Biological Sciences

Volumn 7, Issue 8, 2007, Pages 1296-1304

  Oguntibeju, Oluwafemi O ^a,b   Van den Heever, W M J ^a   Van Schalkwyk, F E ^a  

^a CENTRAL UNIVERSITY OF TECHNOLOGY   (South Africa)

^b West Indies   (South Africa)

Author keywords

Acquired immune deficiency syndrome; Biology; Epidemiology; Human immunodeficiency viras; Pathogenesis

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; T LYMPHOCYTE RECEPTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AFRICA; CD4+ T LYMPHOCYTE; DISEASE CLASSIFICATION; ENVIRONMENTAL FACTOR; EPIDEMIC; GENETIC SUSCEPTIBILITY; GEOGRAPHIC DISTRIBUTION; HEALTH CARE ACCESS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALNUTRITION; NONHUMAN; OPPORTUNISTIC INFECTION; PATHOGENESIS; POVERTY; REVIEW; SEXUAL TRANSMISSION; SUPERINFECTION; SURVIVAL TIME; TUBERCULOSIS; VIRUS LOAD; VIRUS TRANSMISSION;

EID: 37349073725     PISSN: 17273048     EISSN: 18125719     Source Type: Journal    
DOI: 10.3923/jbs.2007.1296.1304     Document Type: Review

References (80)

1. ADSA (Association for Dietetics in Southern Africa), 1996. The role of nutritional intervention in the treatment of human immunodeficiency virus infection in adults. South Afr. Foods Sci. Nutr., 8: 162-164.
2. Bagasra, O., S.P. Hauptman and H.W. Lischener, 1992. Detection of human immunodeficiency virus type 1 provirus on mononuclear cells by in situ polymerase chain reaction. New Engl. J. Med., 326: 1385-1391.
3. Barnhart, H.X., M.B. Caldwell and P. Thomas, 1996. Natural history of human immunodeficiency virus disease in perinatally infected children: An analysis from the Pediatric Spectrum of Disease Project. Pediatrics, 97: 710-716.
4. Bartlett, J.G., 1998. Natural History and Classification of HIV Infection. Chapter 2. In: Medical Management of HIV Infection: 1-15. Bartlett, J.G. (Ed.). Baltimore: Port City Press.
5. Bentwich, Z., A. Kalinkovich and Z. Weisman, 1999. Immune activation in the context of HIV infection. Clin. Exp. Immunol., 111: 1-2.
6. Bragbjerg, I.C., 1993. AIDS in a Danish surgeon. The Lancet, 925: 56-58.
7. Buehler, J.W., De Cock Km and J. Brunet, 1993. Surveillance definitions for AIDS. AIDS 7 (Suppl): pp: S73-S81.
8. Cahill, K.M., 1994. The AIDS Epidemic: African Health, 2: 1-60.
9. Cardo, M., D.H. Culver and C.A. Ciesielski, 1997. A case-control study of HIV seroconversion in health care workers after percutaneous exposure. N. Engl. J. Med., 337: 1485-1490.
10. Centers for Disease Control, 1987. Revision of the CDC case surveillance definition for acquired immunodeficiency syndrome. Monthly Morbidity Weekly Report of CDC Surveillance Summary, 36: Suppl 1S: 3S-14.
11. + T cells. Science, 270: 1811-1915.
12. Cohen, O.J. and A.S. Fauci, 2001. Host factors that affect sexual transmission of HIV. Int. J. Infect. Dis., 2: 182-185.
13. Dannhauser, A., A.M. Van Staden, E. Van der Ryst, M. Nel, N. Marais and E. Erasmus et al., 1999. Nutritional status of HIV-1 sero-positive patients in the Free State Province of South Africa: Anthropometric and dietary profile. Eur. J. Clin. Nutr., 53: 165-173.
14. Dalgleish, A.G. and V. Colizzi, 1992. Role of major histocompatibility complex recognition in the protection and immunopathogenesis of AIDS. AIDS, 6: 523-525.
15. Darby, S.C., D.W. Weart and P.L.F. Giangrande, 1996. Importance of age at infection with HIV-1 for survival and development of AIDS in UK haemophilia population. Lancet, 347: 1573-1579.
16. DeGruchy, G.C., 1990. Clinical Haematology. In: Medical Practice. 5th Edn., University Press, London, pp: 489-493.
17. Denny, T.N., J.H. Skurnick and P. Palumbo, 1998. CD3+CDS+ cell levels as predictors of transmission in human immunodeficiency virus-infected couples: A report from the heterosexual HIV transmission study. Int. J. Infect. Dis., 2: 186-192.
18. DeVincenzi, I., 1994. Longitudinal study of human immunodeficiency transmission by heterosexual partners. N. Engl. J. Med., 331: 341-346.
19. Dhianraj, C., 2000. Institutionalising the response to HIV/AIDS in the South African University sector: A South African University Vice-Chancellor Association (SAUVCA). Technical Report, 1: 8-9.
20. Dorrington, R., D. Bourne, D. Bradshaw, Laubscher and I.M. Timaeus, 2001. The impact of HIV/AIDS on adult mortality in South Africa. Technical Report. MRC, Cape Town, pp: 44-45.
21. Efem, S.E., 1990. AIDS and surgical practice. Nig. Med. Pract., 19: 83-86.
22. Enger, C., N. Graham and Y. Peng, 1996. Survival from early, intermediate and late stages of HIV infection. J. Am. Med. Assoc., 275: 1329-1334.
23. Enwonwu, C.O., 1992. Interface of malnutrition and human immunodeficiency virus infection in sub-Saharan Africa: A critical review. Nutr. Res., 12: 1041-1050.
24. Fauci, A., 1988. The human immunodeficiency virus: Infectivity and mechanisms of pathogenesis. Science, 239: 617-622.
25. Fauci, A.S., S.M. Schnittman and G. Poli, 1991. National Institute of Health Conf: Immunopathogenic mechanisms in Human Immunodeficiency Virus (HIV) infection. Annals. Int. Med., 114: 678-693.
26. Fawzi, W.W. and D.J. Hunter, 1998. Vitamins in HIV disease progression and vertical transmission. Annals. Int. Med., 114: 678-693.
27. Feinberg, M.B., 1995. Human retrovirus infections. Scientific Am. Med., 7: 1-38.
28. Fox, C.H., 1991. Lymphoid germinal centers are reservoirs of HIV infection and account for the apparent latency of infection. AIDS Res. Hum. Retroviruses, 8: 756-758.
29. Fox, C.H., 1996. The pathogenesis of HIV disease. J. Nutr., 126: 2608S-26010.
30. Fox, C.H., K. Enner-Racz, P. Racz, A. Firpa and A.S. Fauci 1992. Lymphoid centers are reservoirs of HIV-1 RNA. J. Infect. Dis., 164: 1051-1057.
31. Fox, C.H. and M. Cottler-Fox, 1992. The pathology of HIV infection. Immunol. Today, 13: 353-356.
32. Fox, C.H., S. Hoover, V.R. Currall, H.I. Bahre and M. Cottler-Fox 1994. HIV in infected Lymph nodes. Nature, 370: 256.
33. Gallant, J.E., 1999. The seropositive patient-the initial encounter. HIV Clinical Management Vol. 1; Medscape.
34. Gilks, C.F., 1993. The clinical challenge of the HIV epidemic in the developing world. Lancet, 148: 1037-1038.
35. Grossman, Z. and R.B. Herberman, 1997. T-cell homoestasis in HIV infection is neither failing nor blind: Modified cell counts reflect an adaptive response of the host. Nature Med., 3: 486-490.
36. + T-cell demographics and dynamics in lymphatic tissues. Ann. Rev. Immunol., 17: 625-656.
37. Haynes, B.F., G. Panteleo and A.S. Fauci, 1996. Toward an understanding of the correlates of protective immunity to HIV infection. Science, 271: 324-328.
38. Hazenberg, M.D., D. Hamann, H. Schuitemaker and F. Miedema, 2000. T cell depletion in HIV-1 infection: How CD4+T cells go out of stock. Nature Immunol., 1: 285-289.
39. Ho, D.D., A.U. Neuman and A.S. Perelson, 1995. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature, 373: 123-126.
40. Hu, D.J., T.J. Dondero and M.A. Rayfield, 1996. The emerging genetic diversity of HIV: The importance of global surveillance for diagnostics, research and prevention. J. Am. Med. Assoc., 275: 210-216.
41. Kaplan, J.E., H. Masur and H.W. Jaffe, 1995. Reducing the impact of opportunistic infections in patients with HIV infection. J. Am. Med. Assoc., 274: 347-348.
42. Koot, M., B. Van't, A. Wout and N.A. Kootstra, 1996. Relation between changes in cellular load evaluation of vital phenotype and the clonal composition of virus type infection. J. Infect. Dis., 173: 349-354.
43. Kreiss, J., D.M. Willerford and M. Hensel, 1997. Association between cervical inflammation and cervical shedding of human immunodeficiency virus DNA. J. Infect. Dis., 170: 1597-601.
44. Kuritzkes, D.R., 1999. HIV pathogenesis and viral markers. HIV Clinical Management. Vol. 2. Medscape, Inc., pp: 25-30.
45. Leroy, V., M.L. Newell and F. Dabis 1998. International multicentre pooled analysis of late postnatal mother-to-child transmission of HIV-1 infection. Lancet, 352: 597-600.
46. Levy, J.A., 1993. Pathogenesis of human immunodeficiency virus infection. Microbiol. Rev., 57: 183-189.
47. Liu, H., D. Chao, E. Nakayama, H. Taguchi, M. Goto and X. Xin et al., 2000. Insights into HIV pathogenesis. Proc. Natl. Acad. Sci., 96: 4581-4585.
48. Macallan, D.C., 1999. Wasting in HIV infection and AIDS. J. Nutr., 129: 238S-242S.
49. MacDouall, D.S., 1997. Quantitative measurement of HIV RNA: Techniques and clinical applications. J. Int. Assoc. Phys. AIDS Care, 2: 9-14.
50. Martin, D., 2000. Appropriate laboratory monitoring of HIV. S Afr. Med. J., 90: 33-35.
51. Maw, M.A., 2000. AIDS epidemiology in Lesotho: Ministry of Health and Social Welfare, Lesotho. Technical Reprot, 1: 1-22.
52. Moore, J.P., A. Trkola and T. Dragic, 1997. Co-receptors for HIV-entry. Curr. Opin. Immunol., 9: 551-556.
53. Oguntibeju, O.O. and O. Banjoko, 2003. A study on the activities of liver enzymes in HIV/AIDS patients. J. Med. Sci., 3: 106-109.
54. Oguntibeju, O.O. and F. Fabode, 2002. Prevalence of sexually transmitted diseases (Gonorrhoea, Trichomoniasis, Candidiasis, Syphilis) and HIV infection among young adults in Oyo, Nigeria. Med. Technol., 16: 351-352.
55. Oguntibeju, O.O., D. Veldman and F. Van Schalkwyk, 2002. Biological, social and environmental factors affecting sexual transmission of HIV infection. Med. Technol., 16: 372-373.
56. Pakker, N.G., 1998. Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: A composite of redistribution and proliferation. Nature Med., 4: 208-214.
57. Pantaleo, G., C. Graziosi and A.S. Fauci, 1998. The immunopathogenesis of human immunodeficiency virus infection. N. Engl. J. Med., 328: 327-335.
58. Paxon, W.A., S.R. Martin and D. Tse, 1996. Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple sexual exposures. Nature Med., 2: 412-417.
59. Piwoz, E.G. and E.A. Preble, 2000. HIV/AIDS and nutrition: A review of the literature and recommendations for nutritional care and support in sub-Saharan Africa. Support for Analysis and Research in Africa (SARA) Project, Bureau for Africa Office of Sustainable Development, 1825 Connectiant Avenue, NW, Washington DC, 2009, 1: 1-22.
60. Royce, R.A., A. Sena and W. Cates, 1997. Sexual transmission of HIV. N. Engl. J. Med., 336: 1072-1078.
61. Sabatier, 1987. AIDS and the Third world. Norwegian Red Cross. A report, pp: 5-75.
62. SAHIVCS, 2001. Course in HIV/AIDS management, pp: 5-40.
63. Schechter, M.T., R.S. Hogg, B. Aylward, K.J. Craib, T.N. Le and J.S. Montaner, 1994. Higher socioeconomic status is associated with slower progression of HIV infection independent of access to health care. J. Clin. Epidemiol., 47: 59-76.
64. Seidlin, M., M. Vogler and Y.S. Lee, 1993. Heterosexual transmission of HIV in a cohort of couples in New York City. AIDS, 7: 1247-1254.
65. Smith, J.W. and R. Nichols, 1991. Barrier efficiency of surgical gowns. Arch. Surg., 126: 756-759.
66. Soderlund, N., K. Zwi, A. Kinghorn and G. Gray, 1999. Preventing vertical transmission of HIV- a cos effectiveness analysis of options available in South Africa. Br. Med. J., 318: 1650-1655.
67. Stein, D.S., J.A. Korvick and S.H. Vermund, 1992. CD4+ lymphocyte cell enumeration For prediction of clinical course of human immunodeficiency virus disease: A Review. J. Infect. Dis., 165: 352-363.
68. Tindall, B. and D.A. Copper, 1991. Primary HIV infection: Host responses and intervention strategies. AIDS 5, pp: 1-14.
69. Ullum, H., A. Lepri and J. Victor, 1998. Production of beta chemokines in Human Immunodeficiency Virus (HIV) infection: Evidence that high levels of macrophage in inflammatory protein-1 beta are associated with a decreased risk of HIV disease progression. J. Infect. Dis., 177: 331-336.
70. UNAIDS, 1999. Differences in HIV spread in four sub-Saharan African cities. A report 14 September, pp: 1-6.
71. UNAIDS, 2000. Global HIV/AIDS epidemic. UNAIDS Fact sheet, pp: 1-26.
72. UNAIDS, 2001. Global HIV/AIDS epidemic. UNAIDS Fact sheet, pp: 1-29.
73. UNAIDS, 2002. Global HIV/AIDS epidemic. UNAIDS Fact sheet, pp: 1-26.
74. USPH/IDSA Prevention of Opportunistic Infections Working Group, 1996. USPH/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: A summary. Ann. Intern. Med., 124: 346-361.
75. Vogt, M.W., D.J. Witt and D.E. Craven, 1997. Isolation patterns of the human immunodeficiency virus from cervical secretions during the menstrual cycle of women at risk for the acquired immunodeficiency syndrome. Ann. Intern. Med., 106: 380-382.
76. Wawer, M.J., N.K. Sewankambo and D. Serwadda, 1999. Control of sexually transmitted diseases for AIDS prevention in Uganda: A randomised community trial. Rakai Project Study Group. Lancet, 353: 525-535.
77. Weiss, R., 1996. HIV receptors and the pathogenesis of AIDS. Sci., 272: 1885-1886.
78. Wong, J.K., M. Hezareh and H.F. Gunthard, 1997. Recovery of replication-competent HIV despite prolonged suppression of plasma viraemia. Sciences, 278: 1291-1295.
79. World Health organization, 1993. World Health Organization (WHO) global programmes on AIDS. Proposed WHO staging system for HIV infection and disease. AIDS, 7: 868-869.
80. Young, J., 1997. HIV and medical nutrition therapy. J. Am. Diet. Assoc., 97: S161-167.